Andrea Cipriani

ORCID: 0000-0001-5179-8321
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Treatment of Major Depression
  • Schizophrenia research and treatment
  • Mental Health Research Topics
  • Bipolar Disorder and Treatment
  • Electroconvulsive Therapy Studies
  • Meta-analysis and systematic reviews
  • Health Systems, Economic Evaluations, Quality of Life
  • Functional Brain Connectivity Studies
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Child and Adolescent Psychosocial and Emotional Development
  • Mental Health Treatment and Access
  • Tryptophan and brain disorders
  • Attention Deficit Hyperactivity Disorder
  • Mental Health and Psychiatry
  • Statistical Methods in Clinical Trials
  • Suicide and Self-Harm Studies
  • Digital Mental Health Interventions
  • COVID-19 and Mental Health
  • Pain Management and Placebo Effect
  • Clinical practice guidelines implementation
  • Pharmaceutical industry and healthcare
  • Telemedicine and Telehealth Implementation
  • Maternal Mental Health During Pregnancy and Postpartum
  • Dementia and Cognitive Impairment Research
  • Health Policy Implementation Science

University of Oxford
2016-2025

Warneford Hospital
2016-2025

Oxford BioMedica (United Kingdom)
2022-2025

Oxford Health NHS Foundation Trust
2016-2025

National Institute for Health Research
2016-2025

National Health Service
2019-2024

University of Manchester
2023

Kyoto University
2019-2023

University of California, Los Angeles
2016-2021

Johns Hopkins University
2016-2021

The British Association for Psychopharmacology guidelines specify the scope and target of treatment bipolar disorder. second version, like first, is based explicitly on available evidence presented, previous Clinical Practice guidelines, as recommendations to aid clinical decision making practitioners: they may also serve a source information patients carers. are presented together with more detailed but selective qualitative review evidence. A consensus meeting, involving experts in...

10.1177/0269881116636545 article EN Journal of Psychopharmacology 2016-03-15

The increase in treatment options creates an urgent need for comparative effectiveness research. Randomized, controlled trials comparing several treatments are usually not feasible, so other methodological approaches needed. Meta-analyses provide summary estimates of effects by combining data from many studies. However, important drawback is that standard meta-analyses can compare only 2 interventions at a time. A new meta-analytic technique, called network meta-analysis (or multiple or...

10.7326/0003-4819-159-2-201307160-00008 article EN Annals of Internal Medicine 2013-07-15

No network meta-analysis has examined the relative effects of psychotherapies, pharmacotherapies and their combination in treatment adult depression, while this is a very important clinical issue. We conducted systematic searches bibliographical databases to identify randomized trials which psychotherapy pharmacotherapy for acute or long-term depression were compared with each other, was either one alone. The main outcome response (50% improvement between baseline endpoint). Remission...

10.1002/wps.20701 article EN World Psychiatry 2020-01-10

Dose equivalence of antidepressants is critically important for clinical practice and research. There are several methods to define calculate dose but antidepressants, only daily defined consensus have been applied date. The purpose the present study examine by a less arbitrary more systematic method.We used data from all randomized, double-blind, flexible-dose trials comparing fluoxetine or paroxetine as standard drugs with any other active monotherapy in acute phase treatment unipolar...

10.1016/j.jad.2015.03.021 article EN cc-by-nc-nd Journal of Affective Disorders 2015-04-05
Coming Soon ...